New York Attorney General Letitia James is suing New York City-based Park Avenue Stem Cell alleging the clinic performed unproven and rogue procedures on patients, the New York Times reports.
Biologics
A new study published in the Journal of Neurosurgery: Spine examines the role of BMP use during spinal deformity cases.
The Journal of Neurosurgery published an article outlining "awake spinal fusion" using the endoscopic transforaminal lumbar interbody fusion technique without general anesthesia.
InVivo Therapeutics reported raising net proceeds of $16.5 million in 2018 and implemented significant cost savings measures last year.
Bioventus launched Osteoamp Select Fibers for use with its bone graft substitutes for spine, foot, ankle orthopedic and trauma surgeons.
Advertisement
Using the bone morphogenetic protein rhBMP-2 in the disc space for minimally invasive transforaminal lumbar interbody fusion led to a 97.9 percent fusion rate, according to a study in Clinical Spine Surgery.
The global spinal biologics market is projected to grow at a 3.6 percent compound annual growth rate to reach $2.55 billion by 2024, according to a Market Study Report.
Here are 13 key players in the global non-metal orthopedic biomaterial market, according to a Markets N Research report.
AlloSource enrolled the first patient in a study of its ProChondrix CR for articular cartilage defect repair.
The FDA cleared Atreon Orthopedics' Rotium Bioresorbable Wick for healing rotator cuff injuries.